These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38751617)

  • 1. Structure-Activity Relationship Study of (
    Wang S; Ge Q; Cong H; Zhang W; Liu H; Qu Z; Chen H; Zhuang C
    ACS Pharmacol Transl Sci; 2024 May; 7(5):1386-1394. PubMed ID: 38751617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure optimization of an F-indole-chalcone (FC116) on 4-methoxyphenyl group and therapeutic potential against colorectal cancers with low cytotoxicity.
    Du B; Liu X; Luan X; Zhang W; Zhuang C
    Bioorg Chem; 2023 Jun; 135():106531. PubMed ID: 37043882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoroindole chalcone analogues targeting the colchicine binding site of tubulin for colorectal oncotherapy.
    Liu X; Jin J; Wu Y; Du B; Zhang L; Lu D; Liu Y; Chen X; Lin J; Chen H; Zhang W; Zhuang C; Luan X
    Eur J Med Chem; 2023 Sep; 257():115540. PubMed ID: 37301075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4 T cells target colorectal cancer antigens upregulated by oxaliplatin.
    Galaine J; Turco C; Vauchy C; Royer B; Mercier-Letondal P; Queiroz L; Loyon R; Mouget V; Boidot R; Laheurte C; Lakkis Z; Jary M; Adotévi O; Borg C; Godet Y
    Int J Cancer; 2019 Dec; 145(11):3112-3125. PubMed ID: 31396953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, in vitro antiproliferative activity and apoptosis-inducing studies of 1-(3',4',5'-trimethoxyphenyl)-3-(2'-alkoxycarbonylindolyl)-2-propen-1-one derivatives obtained by a molecular hybridisation approach.
    Preti D; Romagnoli R; Rondanin R; Cacciari B; Hamel E; Balzarini J; Liekens S; Schols D; Estévez-Sarmiento F; Quintana J; Estévez F
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1225-1238. PubMed ID: 30141353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of capecitabine and oxaliplatin (CAPOX) plus cetuximab in patients with metastatic colorectal cancer who progressed after oxaliplatin-based chemotherapy.
    Souglakos J; Kalykaki A; Vamvakas L; Androulakis N; Kalbakis K; Agelaki S; Vardakis N; Tzardi M; Kotsakis AP; Gioulbasanis J; Tsetis D; Sfakiotaki G; Chatzidaki D; Mavroudis D; Georgoulias V
    Ann Oncol; 2007 Feb; 18(2):305-10. PubMed ID: 17079693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, Characterization, and Biological Study of 3-Trifluoromethylpyrazole Tethered Chalcone-Pyrrole and Pyrazoline-Pyrrole Derivatives.
    Kisan Rasal N; Bhaskar Sonawane R; Vijay Jagtap S
    Chem Biodivers; 2021 Oct; 18(10):e2100504. PubMed ID: 34409724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy, safety and genomic analysis of SCT200, an anti-EGFR monoclonal antibody, in patients with fluorouracil, irinotecan and oxaliplatin refractory RAS and BRAF wild-type metastatic colorectal cancer: a phase Ⅱ study.
    Yang L; Zhang W; Fan N; Cao P; Cheng Y; Zhu L; Luo S; Zong H; Bai Y; Zhou J; Deng Y; Ba Y; Liu T; Aili M; Yin X; Gu K; Dai G; Ying J; Shi J; Gao Y; Li W; Yu G; Xie L; Gai W; Wang Y; Meng P; Shi Y
    EBioMedicine; 2024 Feb; 100():104966. PubMed ID: 38217945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and bioactive evaluation of
    Ren A; Wei W; Liang Z; Zhou M; Liang T; Zang N
    RSC Med Chem; 2023 Jan; 14(1):113-121. PubMed ID: 36760739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II open-label randomized multicenter trial of TSU-68 in combination with S-1 and oxaliplatin versus S-1 in combination with oxaliplatin in patients with metastatic colorectal cancer.
    Lee J; Shin SJ; Chung IJ; Kim TW; Chun HG; Shin DB; Kim YH; Song HS; Han SW; Kim JG; Kim SY; Choi YJ; Chung HC
    Invest New Drugs; 2014 Jun; 32(3):561-8. PubMed ID: 24573743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. aCGH Analysis of Predictive Biomarkers for Response to Bevacizumab plus Oxaliplatin- or Irinotecan-Based Chemotherapy in Patients with Metastatic Colorectal Cancer.
    Fujita Y; Taguri M; Yamazaki K; Tsurutani J; Sakai K; Tsushima T; Nagase M; Tamagawa H; Ueda S; Tamura T; Tsuji Y; Murata K; Taira K; Denda T; Moriwaki T; Funai S; Nakajima TE; Muro K; Tsuji A; Yoshida M; Suyama K; Kurimoto T; Sugimoto N; Baba E; Seki N; Sato M; Shimura T; Boku N; Hyodo I; Yamanaka T; Nishio K
    Oncologist; 2019 Mar; 24(3):327-337. PubMed ID: 30425180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticancer Indole-Based Chalcones: A Structural and Theoretical Analysis.
    Badria FA; Soliman SM; Atef S; Islam MS; Al-Majid AM; Dege N; Ghabbour HA; Ali M; El-Senduny FF; Barakat A
    Molecules; 2019 Oct; 24(20):. PubMed ID: 31623155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. {2-[1-(3-Methoxycarbonylmethyl-1H-indol-2-yl)-1-methyl-ethyl]-1H-indol-3-yl}-acetic Acid Methyl Ester Inhibited Hepatocellular Carcinoma Growth in Bel-7402 Cells and Its Resistant Variants by Activation of NOX4 and SIRT3.
    Li Y; Wang W; Xu X; Sun S; Xu X; Qu XJ
    Biomed Res Int; 2015; 2015():491205. PubMed ID: 25961022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of anlotinib in combination with oxaliplatin and capecitabine for patients with RAS/BRAF wild-type metastatic colorectal adenocarcinoma as the first-line therapy.
    Liu Y; Xiao Q; He J; Hu H; Du J; Zhu Y; Chen J; Liu Z; Wang J; Sun L; Xu D; Li J; Liao X; Wang J; Cai Y; Cai C; Jin Z; Wang L; Yuan Y; Ding K
    BMC Med; 2022 May; 20(1):155. PubMed ID: 35513832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KRAS Testing for Anti-EGFR Therapy in Advanced Colorectal Cancer: An Evidence-Based and Economic Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(25):1-49. PubMed ID: 23074403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gallic Acid Derived 1, 2-Diarylindole as a Potential Antifungal Agent against Candida Strain.
    Kurmi A; Singh AP; Gautam Y; Singh N; Tripathi A; Negi AS; Gautam HK; Pal A; Saikia D
    Curr Top Med Chem; 2024 Feb; ():. PubMed ID: 38549526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Oxaliplatin-based Regimens as First-line Chemotherapy in Elderly Patients With Metastatic Colorectal Cancer.
    Yamamoto S; Fujii H; Murayama K; Iihara H; Watanabe D; Yamada Y; Kobayashi R; Kiyama S; Makiyama A; Urano K; Matsuhashi N; Suzuki A; Matsuura K
    Anticancer Res; 2023 Nov; 43(11):5099-5105. PubMed ID: 37909957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxaliplatin: a review of its use in combination therapy for advanced metastatic colorectal cancer.
    Simpson D; Dunn C; Curran M; Goa KL
    Drugs; 2003; 63(19):2127-56. PubMed ID: 12962525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of weekly 5-fluorouracil/folinic acid/oxaliplatin/irinotecan in the first-line treatment of gastrointestinal cancer.
    Peinert S; Grothe W; Stein A; Müller LP; Ruessel J; Voigt W; Schmoll HJ; Arnold D
    Ther Adv Med Oncol; 2010 May; 2(3):161-74. PubMed ID: 21789132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of 3-phenylquinolinylchalcone derivatives as potent and selective anticancer agents against breast cancers.
    Tseng CH; Tzeng CC; Hsu CY; Cheng CM; Yang CN; Chen YL
    Eur J Med Chem; 2015 Jun; 97():306-19. PubMed ID: 26005780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.